The global kidney function test market size was estimated to be USD 0.903 billion in 2023 and is expected to reach at USD 1.87 billion by 2034 with a CAGR of 6.84% during the forecast period 2024-2034. Rising investments by leading market players, growing research & development activities, increasing prevalence of kidney disorders, surge in government initiatives, rising technological innovations, growing adoption of digital urinalysis, increasing demand for home diagnostics, and surge in technological advancements associated with kidney function tests are some of the key factors boosting the market growth.
Surge in technological advancements associated with kidney function tests is predicted to boost the market growth during the forecast period. The adoption of digital analysis tools by healthcare professionals increases the demand for technologically advanced products. For instance, in July 2022, Healthy.io has obtained 510(k) clearance from the U.S. FDA for the home usage of their Minuteful Kidney test. This marks one of the initial instances of an FDA-cleared smartphone-based home test for assessing albumin to creatinine ratio (ACR).
By product, dipstick was the highest revenue-grossing segment in the global kidney function test market in 2023 owing to its cost effectiveness, rising prevalence of urinary tract infections & kidney disorders, growing launch of novel products, and increasing research & development activities. For instance, in April 2023, According to a publication by Oxford University Press on behalf of the American Medical Informatics Association, machine learning models are employed to identify chronic kidney disease (CKD) without the need for blood samples. These models predict an estimated glomerular filtration rate (eGFR) by analyzing results from a urine dipstick test. Additionally, disposable is predicted to grow at fastest CAGR during the forecast period owing to the increasing prevalence of infectious diseases, growing demand for signle use products, and rising focus on development of new products.
By type, blood tests was the highest revenue-grossing segment in the global kidney function test market in 2023 owing to the increasing adoption of traditional techniques and rising emphasis on production of sophisticated products. Additionally, urine tests is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of renal uremia, increasing investments in the renal function testing industry, and growing launch of advanced tools. For instance, in March 2022, Nova Biomedical has unveiled the Nova Max Pro Creatinine/eGFR Meter System across all CE countries. This system is a significant addition designed to enhance kidney care by facilitating kidney function screening and the early identification of kidney disease in point-of-care environments beyond hospital settings.
By end-user, hospital was the highest revenue-grossing segment in the global kidney function test market in 2023 owing to the growing number of hospitalizations, rising demand for diagnostic interpretation by doctors for further treatment, surge in initiatives by healthcare organizations to promote the use of advanced diagnostic tests, and increasing focus on development of innovative test kits. For instance, in August 2022, Bloom Diagnostics has created an intelligent system capable of identifying a wide array of medical conditions. The most recent addition to their lineup is the Bloom Kidney Test, which measures cystatin C levels in the blood to quantitatively assess GFR, thereby indicating the health status of the kidneys. Additionally, diagnostic laboratories is predicted to grow at fastest CAGR during the forecast period owing to the rising awareness regarding CKD, increasing demand for affordable services, and surge in technological advancements.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising well-established healthcare infrastructure, growing awareness about CKD, surge in favorable reimbursement policies, and increasing approvals by regulatory bodies. For instance, in July 2022, The United States Food and Drug Administration (FDA) has granted clearance to bioMérieux for their VIDAS NEPHROCHECK assay, an innovative diagnostic tool designed to identify kidney stress in patients who are vulnerable to acute kidney injury (AKI). Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of kidney disease, surge in number of kidney transplants, increase in urinary tract infections, and rising focus on development of innovative products. For instance, in February 2023, Three graduates from the renowned Indian Institute of Technology, Bombay (IIT-B), have created NeoDocs, a health testing kit that operates on smartphones and provides test results within just 30 seconds using a urine sample.
Surge in technological advancements associated with kidney function tests is predicted to boost the market growth during the forecast period. The adoption of digital analysis tools by healthcare professionals increases the demand for technologically advanced products. For instance, in July 2022, Healthy.io has obtained 510(k) clearance from the U.S. FDA for the home usage of their Minuteful Kidney test. This marks one of the initial instances of an FDA-cleared smartphone-based home test for assessing albumin to creatinine ratio (ACR).
By product, dipstick was the highest revenue-grossing segment in the global kidney function test market in 2023 owing to its cost effectiveness, rising prevalence of urinary tract infections & kidney disorders, growing launch of novel products, and increasing research & development activities. For instance, in April 2023, According to a publication by Oxford University Press on behalf of the American Medical Informatics Association, machine learning models are employed to identify chronic kidney disease (CKD) without the need for blood samples. These models predict an estimated glomerular filtration rate (eGFR) by analyzing results from a urine dipstick test. Additionally, disposable is predicted to grow at fastest CAGR during the forecast period owing to the increasing prevalence of infectious diseases, growing demand for signle use products, and rising focus on development of new products.
By type, blood tests was the highest revenue-grossing segment in the global kidney function test market in 2023 owing to the increasing adoption of traditional techniques and rising emphasis on production of sophisticated products. Additionally, urine tests is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of renal uremia, increasing investments in the renal function testing industry, and growing launch of advanced tools. For instance, in March 2022, Nova Biomedical has unveiled the Nova Max Pro Creatinine/eGFR Meter System across all CE countries. This system is a significant addition designed to enhance kidney care by facilitating kidney function screening and the early identification of kidney disease in point-of-care environments beyond hospital settings.
By end-user, hospital was the highest revenue-grossing segment in the global kidney function test market in 2023 owing to the growing number of hospitalizations, rising demand for diagnostic interpretation by doctors for further treatment, surge in initiatives by healthcare organizations to promote the use of advanced diagnostic tests, and increasing focus on development of innovative test kits. For instance, in August 2022, Bloom Diagnostics has created an intelligent system capable of identifying a wide array of medical conditions. The most recent addition to their lineup is the Bloom Kidney Test, which measures cystatin C levels in the blood to quantitatively assess GFR, thereby indicating the health status of the kidneys. Additionally, diagnostic laboratories is predicted to grow at fastest CAGR during the forecast period owing to the rising awareness regarding CKD, increasing demand for affordable services, and surge in technological advancements.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising well-established healthcare infrastructure, growing awareness about CKD, surge in favorable reimbursement policies, and increasing approvals by regulatory bodies. For instance, in July 2022, The United States Food and Drug Administration (FDA) has granted clearance to bioMérieux for their VIDAS NEPHROCHECK assay, an innovative diagnostic tool designed to identify kidney stress in patients who are vulnerable to acute kidney injury (AKI). Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of kidney disease, surge in number of kidney transplants, increase in urinary tract infections, and rising focus on development of innovative products. For instance, in February 2023, Three graduates from the renowned Indian Institute of Technology, Bombay (IIT-B), have created NeoDocs, a health testing kit that operates on smartphones and provides test results within just 30 seconds using a urine sample.
Segmentation: Kidney Function Test Market Report 2022 - 2033
Kidney Function Test Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Reagents
- Dipsticks
- Disposables
Kidney Function Test Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
Urine Tests
- Urine Protein Tests
- Creatinine Clearance Tests
- Microalbumin Tests
Blood Tests
- Serum Creatinine Tests
- Blood Urea Nitrogen Tests
- Glomerular Filtration Rate Tests
Kidney Function Test Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Diagnostic Laboratories
- Hospitals
- Research Laboratories And Institutes
- Others
Kidney Function Test Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Kidney Function Test Market: Product Estimates & Trend Analysis
8. Kidney Function Test Market: Type Estimates & Trend Analysis
9. Kidney Function Test Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Kidney Function Test Market
12. Europe Global Kidney Function Test Market
13. Asia Pacific Global Kidney Function Test Market
14. Latin America Global Kidney Function Test Market
15. MEA Global Kidney Function Test Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- bioMérieux SA
- Merck KGaA
- Abbott
- F. Hoffmann-La Roche Ltd.
- Beckman Coulter
- Sysmex Corporation
- Siemens Healthineers
- Nova Biomedical Corporation
- Quest Diagnostics
- Arkray Inc.
- URIT Medical Electronic Co. Ltd
- 77 Elektronika Kft
- ACON Laboratories Inc.
- Danaher
- Laboratory Corporation of America Holdings
- Randox Laboratories Ltd
- OPTI Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | October 2023 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 0.9 Billion |
| Forecasted Market Value ( USD | $ 1.87 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
